Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients.

about

High-risk multiple myeloma: a multifaceted entity, multiple therapeutic challenges.

P2860

Q38979403-94D88A9F-A529-4B32-B34D-07D40ABF4E34

P2860

Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients.

Item

http://www.wikidata.org/entity/Q40928974

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Impact of Genes Highly Correla ...... of Non-MMSET Myeloma Patients.

@en

type

Item

label

Impact of Genes Highly Correla ...... of Non-MMSET Myeloma Patients.

@en

prefLabel

Impact of Genes Highly Correla ...... of Non-MMSET Myeloma Patients.

@en

P1476

Impact of Genes Highly Correla ...... of Non-MMSET Myeloma Patients.

@en

P2093

Gareth Morgan

http://www.w3.org/2001/XMLSchema#string

Inhye E Ahn

http://www.w3.org/2001/XMLSchema#string

Mark van Duin

http://www.w3.org/2001/XMLSchema#string

Nikhil C Munshi

http://www.w3.org/2001/XMLSchema#string

Ruth M Pfeiffer

http://www.w3.org/2001/XMLSchema#string

S Peter Wu

http://www.w3.org/2001/XMLSchema#string

Sham Mailankody

http://www.w3.org/2001/XMLSchema#string

P2860

p53 represses c-Myc through induction of the tumor suppressor miR-145

Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients

Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival

A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts

A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma

p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest.

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.

Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation

P2880

20050747

http://www.w3.org/2001/XMLSchema#string

P304

4039-4044

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-15-2366

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brian A. Walker

Ola Landgren

Pieter Sonneveld

P577

2016-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26847058

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

P932

5576175

http://www.w3.org/2001/XMLSchema#string

Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients.

about

P2860

P2860

Impact of Genes Highly Correlated with MMSET Myeloma on the Survival of Non-MMSET Myeloma Patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2880

P304

P31

P356

P407

P433

P478

P50

P577

P698

P859

P921

P932

P356

P1433

P1476

P2093

P2860

P2880

P304

P31

P356

P407

P433

P478

P50

P577

P698

P859

P921

P932